Regulatory approval of Pfizer/BioNTech vaccine for COVID-19, MHRA (updated 28th June 2021)

Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine. 28 June 2021 Updated the Public Assessment report, to reflect the extension to the current UK approval of the Pfizer/BioNTech COVID-19 vaccine that allows its use in 12- to 15-year-olds, as announced on 4 June 2021. 25 June 2021 A dded a warning on myocarditis to the Information for UK recipients and the Information for Healthcare Professionals
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news